VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Conditioning with bortezomib and melphalan in myeloma

Meral Beksac, MD, Ankara University School of Medicine, Ankara, Turkey, discusses a study evaluating conditioning with bortezomib-melphalan versus melphalan in patients with multiple myeloma prior to autologous hematopoietic cell transplantation. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter